Pangenomic Health Inc.
NARA
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 274.20K | 531.80K | 542.40K | 481.40K | 424.90K |
| Gross Profit | -274.20K | -531.80K | -542.40K | -481.40K | -424.90K |
| SG&A Expenses | 2.01M | 1.57M | 527.00K | 448.20K | 389.00K |
| Depreciation & Amortization | 400.00 | 400.00 | 1.80K | 4.00K | 6.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.28M | 2.10M | 1.07M | 938.60K | 807.20K |
| Operating Income | -2.28M | -2.10M | -1.07M | -938.60K | -807.20K |
| Income Before Tax | -2.47M | -2.45M | -1.31M | -2.89M | -2.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.47 | -2.45 | -1.31 | -2.89 | -2.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.47M | -2.45M | -1.31M | -2.89M | -2.77M |
| EBIT | -2.28M | -2.10M | -1.07M | -938.60K | -807.20K |
| EBITDA | -2.28M | -2.10M | -1.07M | -934.50K | -800.90K |
| EPS Basic | -0.17 | -0.25 | -0.19 | -0.51 | -0.54 |
| Normalized Basic EPS | -0.10 | -0.14 | -0.10 | -0.11 | -0.13 |
| EPS Diluted | -0.17 | -0.26 | -0.20 | -0.51 | -0.55 |
| Normalized Diluted EPS | -0.10 | -0.14 | -0.10 | -0.11 | -0.13 |
| Average Basic Shares Outstanding | 62.57M | 42.12M | 32.94M | 24.61M | 19.47M |
| Average Diluted Shares Outstanding | 62.57M | 42.12M | 32.94M | 24.61M | 19.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |